These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 34153573)

  • 21. Corrigendum to "Photocytotoxic oxovanadium(IV) complexes of ferrocenyl-terpyridine and acetylacetonate derivatives" [Eur. J. Med. Chem. 92 (2015) 332-341].
    Balaji B; Balakrishnan B; Perumalla S; Karande AA; Chakravarty AR
    Eur J Med Chem; 2019 Aug; 175():1. PubMed ID: 31055148
    [No Abstract]   [Full Text] [Related]  

  • 22. Corrigendum to <' Omipalisib inspired macrocycles as dual PI3K/mTOR inhibitors' [Eur. J. Med. Chem. 211 (2021), 113109].
    Alvarez RM; García AB; Riesco-Fagundo C; Martín JI; Varela C; Rodríguez Hergueta A; González Cantalapiedra E; Oyarzabal J; Di Geronimo B; Lorenzo M; Albarrán MI; Cebriá A; Cebrián D; Martínez-González S; Blanco-Aparicio C; Pastor J
    Eur J Med Chem; 2021 Nov; 224():113703. PubMed ID: 34284231
    [No Abstract]   [Full Text] [Related]  

  • 23. Corrigendum to "Synthesis and evaluation of isoprenylation-resveratrol dimer derivatives against Alzheimer's disease" [Eur. J. Med. Chem. 163 (2019), 307-319. DOI: 10.1016/j.ejmech.2018.11.040].
    Tang YW; Shi CJ; Yang HL; Cai P; Liu QH; Yang XL; Kong LY; Wang XB
    Eur J Med Chem; 2024 Sep; 275():116591. PubMed ID: 38890013
    [No Abstract]   [Full Text] [Related]  

  • 24. Corrigendum to "Synthesis and preliminary antiproliferative activity of new pteridin-7(8H)-one derivatives" [Eur. J. Med. Chem. 143 (2018) 1396-1405].
    Li ZH; Zhao TQ; Liu XQ; Zhao B; Wang C; Geng PF; Cao YQ; Fu DJ; Jiang LP; Yu B; Liu HM
    Eur J Med Chem; 2019 Nov; 181():111387. PubMed ID: 31376565
    [No Abstract]   [Full Text] [Related]  

  • 25. Corrigendum to "Design, synthesis and evaluation of hybrid of tetrahydrocarbazole with 2,4-diaminopyrimidine scaffold as antibacterial agents" [Eur. J. Med. Chem. 162 (162) (2019) 203-211].
    Su L; Li J; Zhou Z; Huang D; Zhang Y; Pei H; Guo W; Wu H; Wang X; Liu M; Yang CG; Chen Y
    Eur J Med Chem; 2019 Apr; 168():385. PubMed ID: 30826513
    [No Abstract]   [Full Text] [Related]  

  • 26. Corrigendum to "Blockade of STAT3 activation by sorafenib derivatives through enhancing SHP-1 phosphatase activity" [Eur. J. Med. Chem. 55 (2012) 220-227].
    Chen KF; Tai WT; Hsu CY; Huang JW; Liu CY; Chen PJ; Kim I; Shiau CW
    Eur J Med Chem; 2018 Jan; 143():2015. PubMed ID: 29113744
    [No Abstract]   [Full Text] [Related]  

  • 27. Corrigendum to "6-Amino-2,4,5-trimethylpyridin-3-ols: A new general synthetic route and antiangiogenic activity" [Eur. J. Med. Chem. 74 (2014) 126-139].
    Kim DG; Kang Y; Lee H; Lee EK; Nam TG; Kim JA; Jeong BS
    Eur J Med Chem; 2017 Dec; 141():734-735. PubMed ID: 28988929
    [No Abstract]   [Full Text] [Related]  

  • 28. Corrigendum to "From irreversible to reversible covalent inhibitors: Harnessing the andrographolide scaffold for anti-inflammatory action" [Eur. J. Med. Chem. 204 (2020) 112481].
    Tran QTN; Tan DWS; Wong WSF; Chai CLL
    Eur J Med Chem; 2021 Jan; 209():112943. PubMed ID: 33097302
    [No Abstract]   [Full Text] [Related]  

  • 29. Corrigendum to "Design, synthesis and anticancer properties of isocombretapyridines as potent colchicine binding site inhibitors" [Eur. J. Med. Chem. 197 (2020) 112308].
    Shuai W; Li X; Li W; Xu F; Lu L; Yao H; Yang L; Zhu H; Xu S; Zhu Z; Xu J
    Eur J Med Chem; 2020 Aug; 200():112464. PubMed ID: 32512484
    [No Abstract]   [Full Text] [Related]  

  • 30. Corrigendum to: Third-generation CDK inhibitors: A review on the synthesis and binding modes of Palbociclib, Ribociclib and Abemaciclib [Eur. J. Med. Chem. 172 (2019) 143-153].
    Poratti M; Marzaro G
    Eur J Med Chem; 2020 Jun; 195():112272. PubMed ID: 32251743
    [No Abstract]   [Full Text] [Related]  

  • 31. Corrigendum to "Discovery of novel nonsteroidal VDR agonists with novel diarylmethane skeleton for the treatment of breast cancer" [Eur. J. Med. Chem. 163 (2019) 787-803].
    Wang C; Wang B; Hou S; Xue L; Kang Z; Du J; Li Y; Liu X; Wang Q; Zhang C
    Eur J Med Chem; 2020 Jan; 186():111907. PubMed ID: 31791642
    [No Abstract]   [Full Text] [Related]  

  • 32. Corrigendum to "Design, synthesis, and biological evaluation of a new class of histone acetyltransferase p300 inhibitors" [Eur. J. Med. Chem. 180 (2019) 171e190].
    Liu R; Zhang Z; Yang H; Zhou K; Geng M; Zhou W; Zhang M; Huang X; Li Y
    Eur J Med Chem; 2020 Jan; 186():111899. PubMed ID: 31787358
    [No Abstract]   [Full Text] [Related]  

  • 33. Corrigendum to "1,4-Naphthoquinones as inhibitors of Itch, a HECT domain-E3 ligase, and tumor growth suppressors in multiple myeloma" [Eur. J. Med. Chem. 140 (2017) 84-91].
    Liu YM; HuangFu WC; Huang HL; Wu WC; Chen YL; Yen Y; Huang HL; Nien CY; Lai MJ; Pan SL; Liou JP
    Eur J Med Chem; 2020 Sep; 202():112633. PubMed ID: 32688164
    [No Abstract]   [Full Text] [Related]  

  • 34. Corrigendum to "Discovery of orally active anticancer candidate CFI-400945 derived from biologically promising spirooxindoles: Success and challenges" [Eur. J. Med. Chem. 95 (2015) 35-40].
    Yu B; Yu Z; Qi PP; Yu DQ; Liu HM
    Eur J Med Chem; 2016 Nov; 124():248. PubMed ID: 27592393
    [No Abstract]   [Full Text] [Related]  

  • 35. Corrigendum to "Search for new multi-target compounds against Alzheimer's disease among histamine H
    Bajda M; Łażewska D; Godyń J; Zaręba P; Kuder K; Hagenow S; Łątka K; Stawarska E; Stark H; Kieć-Kononowicz K; Malawska B
    Eur J Med Chem; 2020 Nov; 205():112611. PubMed ID: 32791398
    [No Abstract]   [Full Text] [Related]  

  • 36. Corrigendum to "Discovery of new azoles with potent activity against Candida spp. and Candida albicans biofilms through virtual screening" [Eur. J. Med. Chem. 179 (2019) 634-648].
    Sari S; Kart D; Öztürk N; Kaynak FB; Gencel M; Taşkor G; Karakurt A; Saraç S; Eşsiz Ş; Dalkara S
    Eur J Med Chem; 2020 Mar; 190():112130. PubMed ID: 32074493
    [No Abstract]   [Full Text] [Related]  

  • 37. Corrigendum to "Design, synthesis, DFT study and antifungal activity of the derivatives of pyrazolecarboxamide containing thiazole or oxazole ring" [Eur. J. Med. Chem. 149 (2018) 170-181].
    Yan Z; Liu A; Huang M; Liu M; Pei H; Huang L; Yi H; Liu W; Hu A
    Eur J Med Chem; 2018 May; 152():392. PubMed ID: 29747120
    [No Abstract]   [Full Text] [Related]  

  • 38. Corrigendum to "Discovery of a potent, selective and cell active inhibitor of m6A demethylase ALKBH5" [Eur. J. Med. Chem. 238 (2022) 114446].
    Fang Z; Mu B; Liu Y; Guo N; Xiong L; Guo Y; Xia A; Zhang R; Zhang H; Yao R; Fan Y; Li L; Yang S; Xiang R
    Eur J Med Chem; 2023 Jul; 255():115368. PubMed ID: 37119665
    [No Abstract]   [Full Text] [Related]  

  • 39. Corrigendum to "Synthesis and evaluation of 2,5-furan, 2,5-thiophene and 3,4-thiophene-based derivatives as CXCR4 inhibitors" [Eur. J. Med. Chem. 181 (2019) 111562].
    Gaines T; Garcia F; Virani S; Liang Z; Yoon Y; Oum YH; Shim H; Mooring SR
    Eur J Med Chem; 2023 Dec; 261():115753. PubMed ID: 37634992
    [No Abstract]   [Full Text] [Related]  

  • 40. Corrigendum to "Design, synthesis, and biological evaluation of novel tetrahydroprotoberberine derivatives to reduce SREBPs expression for the treatment of hyperlipidemia" [Eur. J. Med. Chem. 221 (2021) 113522].
    Ge H; Zhang W; Yuan K; Xue H; Cheng H; Chen W; Xie Y; Zhang J; Xu X; Yang P
    Eur J Med Chem; 2022 Jan; 228():114041. PubMed ID: 34902733
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.